How should a 76‑year‑old woman with multinodular goitre on carbimazole, suppressed TSH, low‑normal T3 and a total T4 of 110.1 nmol/L (within the assay reference range 66–181 nmol/L) be managed endocrinologically before elective hip surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Preoperative Management of Multinodular Goitre with Suppressed TSH Before Elective Hip Surgery

This patient should continue carbimazole and have beta-blockade added before surgery, with the goal of achieving euthyroidism or at minimum adequate beta-blockade to prevent perioperative thyroid storm or cardiovascular complications. While the T4 is within normal range, the suppressed TSH indicates ongoing thyroid autonomy that poses surgical risk.

Clinical Assessment and Risk Stratification

This 76-year-old woman presents with:

  • Suppressed TSH (indicating thyroid autonomy from multinodular goitre)
  • Normal T4 (110.1 nmol/L, within 66-181 range)
  • Low-normal T3 (specific value not provided)
  • Already on carbimazole therapy

The suppressed TSH with normal thyroid hormones represents subclinical hyperthyroidism, which carries significant perioperative cardiovascular risk, particularly in elderly patients 1, 2.

Key Pathophysiology Consideration

Critical caveat: During carbimazole therapy, T3 levels fall more slowly than T4, and patients may appear biochemically euthyroid by T4 measurement while remaining clinically hyperthyroid 3. The T4:T3 ratio becomes abnormally low during antithyroid drug treatment, making T3 the best indicator of true thyroid status in patients on carbimazole 3. Your patient's "low-normal T3" is reassuring but requires verification that it's truly normal, not just relatively low compared to previously elevated levels.

Immediate Preoperative Management Algorithm

Step 1: Optimize Thyroid Status (Ideally 2-4 Weeks Before Surgery)

Continue carbimazole at current or adjusted dose to achieve:

  • Normal TSH (or as close as achievable)
  • Normal free T3 (most important parameter on carbimazole) 3
  • Normal T4

If euthyroidism cannot be achieved in time (which is common in elderly patients with multinodular goitre 2):

Step 2: Add Beta-Blockade (Essential)

Beta-adrenergic blockade is mandatory for elderly patients with cardiovascular risk undergoing surgery with suppressed TSH 1, 2. The guidelines specifically state that patients with toxic multinodular goitre who are elderly or have cardiovascular disease should receive beta-blockade prior to any intervention and until euthyroidism is achieved 1.

  • Start propranolol 20-40 mg three times daily (or equivalent beta-blocker)
  • Titrate to resting heart rate 60-80 bpm
  • Continue throughout perioperative period

Step 3: Consider Potassium Iodide (If Time Permits)

While the guidelines emphasize potassium iodide for thyroidectomy preparation 1, this may be considered for 7-10 days preoperatively for non-thyroid surgery in patients with uncontrolled hyperthyroidism:

  • Lugol's solution 5-7 drops (0.25-0.35 mL) three times daily, OR
  • SSKI 1-2 drops (0.05-0.1 mL) three times daily

Caution: Do not use iodine for more than 10-14 days, as it may lose effectiveness and potentially worsen thyrotoxicosis.

Perioperative Monitoring

Anesthesia Team Communication

Inform the anesthesiologist about:

  • Suppressed TSH with multinodular goitre
  • Risk of thyroid storm (though lower with hip surgery than thyroid surgery)
  • Current antithyroid medication regimen
  • Beta-blocker coverage

Intraoperative Considerations

  • Avoid sympathomimetic agents when possible
  • Maintain adequate beta-blockade
  • Monitor for tachycardia, hyperthermia, or other signs of thyroid storm

Postoperative Management

  • Continue carbimazole throughout hospitalization 1
  • Continue beta-blocker and wean only after confirming stable thyroid status postoperatively 1
  • Monitor for signs of thyroid storm (fever, tachycardia, altered mental status, cardiovascular instability)

Common Pitfalls to Avoid

  1. Assuming normal T4 means safe for surgery: The suppressed TSH indicates ongoing thyroid autonomy that increases cardiovascular and metabolic stress during surgery 1, 2.

  2. Relying solely on T4 in patients on carbimazole: T3 is the better indicator of thyroid status during antithyroid drug therapy 3. Verify the actual T3 value is truly normal.

  3. Stopping carbimazole perioperatively: There is no indication to stop antithyroid drugs for non-thyroid surgery. Continue throughout 1.

  4. Omitting beta-blockade in elderly patients: This is the most critical error. Elderly patients with suppressed TSH and cardiovascular risk factors require beta-blockade before any surgical stress 1, 2.

  5. Delaying surgery unnecessarily: If adequate beta-blockade is achieved and the patient is clinically stable (even if TSH remains suppressed), hip surgery can proceed safely. The hip surgery should not be indefinitely delayed for perfect thyroid control 1.

Long-Term Consideration

After recovery from hip surgery, this patient should be evaluated for definitive treatment of the multinodular goitre (radioactive iodine or thyroidectomy) rather than indefinite carbimazole therapy 1, 2. Long-term low-dose antithyroid drugs may be appropriate only in fragile patients without serious cardiovascular pathology 2, but definitive treatment is generally preferred in patients with persistent suppressed TSH 1.

References

1
Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

3
Research

Thyroid function tests during carbimazole therapy.

Postgraduate medical journal, 1980

Related Questions

In a patient with a nodular colloid goiter scheduled for surgery, does pre‑operative clearance require thyroid function tests such as free T4 (FT4), free T3 (FT3), and TSH?
Should the patient be referred to an endocrinologist for evaluation of bilateral thyromegaly with a persistent stable multinodular goiter?
What is the management approach for a patient with a benign colloid nodule and toxic multinodular (c) goitre?
According to the American Thyroid Association guidelines, what postoperative management and surveillance are recommended for a patient with multiple non‑toxic goiters who has undergone total thyroidectomy?
In a 76‑year‑old female with a non‑toxic multinodular goitre on carbimazole 5 mg twice daily, suppressed thyroid‑stimulating hormone, low‑normal triiodothyronine, elevated thyroxine, and HbA1c 6.01 % undergoing pre‑operative assessment for orthopedic hip surgery, what endocrine review and peri‑operative management should be documented?
How many days does it take for full recovery from reactive knee arthritis following Mycoplasma pneumoniae infection?
In a 76‑year‑old female with a non‑toxic multinodular goitre on carbimazole 5 mg twice daily, suppressed thyroid‑stimulating hormone, low‑normal triiodothyronine, elevated thyroxine, and HbA1c 6.01 % undergoing pre‑operative assessment for orthopedic hip surgery, what endocrine review and peri‑operative management should be documented?
In a patient with no personal or family history of cardiovascular disease but with elevated low‑density lipoprotein cholesterol, is it reasonable for the patient to be hesitant to start statin therapy because of diabetes risk, and what management strategies should be considered?
Which of the following statements about aspirin is false? A) It irreversibly inhibits cyclooxygenase‑1. B) It has a proven benefit when administered to individuals with established cardiovascular disease. C) It increases the risk of gastrointestinal bleeding. D) Its antiplatelet effect lasts 7–10 days. E) Its administration at a dose of 75–100 mg daily is recommended for primary prevention in individuals at moderate cardiovascular risk.
What is Kikuchi disease, including its definition, clinical presentation, diagnosis, and treatment options?
In Omani pediatric patients receiving vancomycin with subtherapeutic trough levels, what are the likely causes and how should the dosing be adjusted?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.